Shandong Kexing Bioproducts Co., Ltd.

Plant Introduction
Located in Shangdong Mingshui Development Zone in China, its production site offers at commercial scale Erythropoietin, recombinant human granulocyte colony-stimulating factor injection, and combined clostridium butyricum and bifidobacterium capsules, live. Its unit for genetically engineered drugs has floor area of 1,500 square meters, and unit for micro-ecological drugs over 2,000 square meters. Both units have passed China’s GMP certification. 
                                                                                                                         
Its marketing and sales team targeting Chinese market consists of over 30 specialists located in major Chinese cities. The products are available in over 1,000 hospitals, clinics, and dialysis centers around China. Its international marketing and sales team has over 10 years’ experience. They bring the products to over 10 countries in South America, Southeast Asia, Africa, Middle East, and East Europe.

Geographical Advantages
The company is located in mid- Shandong Peninsula. It is eastern to Jinan, the provincial capital of Shandong. It is 1.5 hours' drive from Jinan Airport and 3 hours' drive from Qingdao Port. The company maintains good cooperation with The Medical School of Shandong University, Shandong University of Traditional Chinese Medicine, and Shandong Provincial Hospital of Traditional Chinese Medicine.